RecruitingNCT06291597
Vaping Adverse Lung and Heart Events Cohort
VapALERT: A Prospective, Exploratory and Adaptive Cohort Study to Identify Symptomatic and Asymptomatic Pulmonary and Cardiovascular Effects of Vaping
Sponsor
Laval University
Enrollment
250 participants
Start Date
Oct 14, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This prospective study assesses the pulmonary and cardiovascular effets of vaping in adult electronic cigarette users with biannual visits and a 5-year follow-up.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age 18 years or older
- Daily electronic cigarette user
- No respiratory infection in the 4 weeks before a visit
Exclusion Criteria1
- Women who are pregnant or breast-feeding.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERVaping
Participants use their vaping products at their own discretion and their intake is monitored via questionnaires.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06291597
Related Trials
Effect of Menthol on ENDS Users' Addiction and Exposure
NCT053388011 location
Developing and Testing Health Warning Labels on the ENDS Device
NCT049071361 location
The Canadian Lung Outcomes in Users of Vaping Devices Study
NCT068199698 locations
The Use of tDCS for Vaping Reduction
NCT068856061 location
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
NCT068041091 location